Interstitial lung diseases (ILDs) encompass more than 100 conditions. They represent a heterogeneous group of acute or chronic lung diseases that are characterized—to varying degrees—by inflammation and uncontrolled connective tissue formation, leading to scarring and stiffening of the lungs. The initial presentation of IPF is insidious dyspnea on exertion and a dry cough; the prognosis is poor.
Autoren
- Melika Piric
- Prof. Dr. med. Philipp Markart
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Malignant oral squamous cell carcinomas (OPSCC/HNSCC)
Innovative Treatment Options
- Acne vulgaris: Topical and Systemic Treatment Options
Spotlight on “Hot Topics”
- Asthma: GINA Guidelines 2026
Focusing Not Only on Treating Symptoms, but Also on Reducing Risk
- Psychiatric Self-Diagnoses
When ADHD and Autism Suddenly Become “Trendy”
- Xerosis cutis in Older Adults
Emollients with humectants such as urea or glycerin: clinical evidence
- Casuistry
Chronic eosinophilic pneumonia in RA
- Case Study: Secondary Pseudohypoaldosteronism
Severe electrolyte imbalances and nonspecific symptoms in an infant
- CKD and High Blood Pressure